TinyButStrong Error when merging block "item_offer": unsupported variable type : 'NULL'.

TinyButStrong Error in field [var.itemIDs...]: the key 'itemIDs' does not exist or is not set in VarRef. (VarRef seems refers to $GLOBALS) This message can be cancelled using parameter 'noerr'.

TinyButStrong Error in field [var.itemIDs...]: the key 'itemIDs' does not exist or is not set in VarRef. (VarRef seems refers to $GLOBALS) This message can be cancelled using parameter 'noerr'.

TinyButStrong Error in field [var.itemIDs...]: the key 'itemIDs' does not exist or is not set in VarRef. (VarRef seems refers to $GLOBALS) This message can be cancelled using parameter 'noerr'.

TinyButStrong Error in field [var.itemIDs...]: the key 'itemIDs' does not exist or is not set in VarRef. (VarRef seems refers to $GLOBALS) This message can be cancelled using parameter 'noerr'.
(±)-amg 487 CSN22618-10mg Inhibitors, Activator | tebu-bio
tebu-bio is a European company specialised in providing innovative reagents and laboratory services in Life Sciences
X

Need an answer now?

Give us a call

Leave a message, we'll get back to you





Move

Product added to your basket !


Continue your visit View your basket
[item_offer.size;block=div;when [item_offer.priceMicrodata;noerr]+-0] EUR [item_offer.priceMicrodata;noerr;magnet=span;]
[item_offer.price;magnet=span;noerr;htmlconv=no]
[item_offer.oldprice;magnet=span;noerr;htmlconv=no]   Save [item_offer.save;magnet=span;noerr;frm='0']%
[item_offer.buynow;noerr;htmlconv=no]
[item_offer.size;block=div;default]
[item_offer.buynow;noerr;htmlconv=no]


Contact us

Recent History

(±)-amg 487

Product name
(±)-amg 487
Catalog number
Description
(±)-AMG 487 is an antagonist of CXCR3 that inhibits binding of 125I-IP-10 and 125I-ITAC to CXCR3 with IC50 of 8.0 and 8.2 nM respectively. 
Source
CSNpharm
Product category
Molecules
Product sub category
Inhibitors & Activators
Target's name
CXCR
Biological activity
 
Pathway
Immunology/Inflammation
CAS number
947536-03-0
Shipment info
Cool Pack
Nacres Codification
NA.28

Protocol

To access the protocol, please provide your email address :